Pharmaceutical Filtration Market To Elevate Growth With 12.1% CAGR Till 2025, Owing To Rising Emphasis on Biologics And Their Development For Treatment of Various Diseases | Grand View Research, Inc.

June 09 06:26 2022
Pharmaceutical Filtration Market To Elevate Growth With 12.1% CAGR Till 2025, Owing To Rising Emphasis on Biologics And Their Development For Treatment of Various Diseases | Grand View Research, Inc.
Grand View Research, Inc. – Market Research And Consulting.
According to a new report published by Grand View Research, the increasing investment in research and development of biologics is one of the prime factors attributing to the pharmaceutical filtration industry growth.

Pharmaceutical Filtration Industry Overview

The global pharmaceutical filtration market size was estimated at USD 13.7 billion in 2016 and is expected to reach USD 37.3 billion by the year 2025, growing at a CAGR of 12.1% during forecast period.

Increasing emphasis on biologics and their development for the treatment of various diseases is a major attribute expected to trigger growth. The increase in the number of chronic diseases globally is one of the prime reasons for the growth of the pharmaceutical industry. There is a high demand for advanced therapeutic drugs for the treatment of chronic diseases such as cancer, diabetes, asthma, COPD, and arthritis. Moreover, the production of novel biologics requires utmost sterility and zero risks of contamination which further necessitates the application of advanced filtration products for the manufacturing of drugs and biologics.

Gather more insights about the market drivers, restrains and growth of the Global Pharmaceutical Filtration Market

Increasing investment in research and development of biologics is another prime factor attributing to the growth. The rapid adoption of innovative treatment therapies such as therapeutic proteins, monoclonal antibodies, and vaccines has resulted in an increased number of various biotechnology and biopharmaceutical companies that utilize filtration systems including membranes, cartridges, capsules, and other products.


U.S. pharmaceutical filtration market, by product, 2014 – 2025 (USD million)

U.S. Pharmaceutical Filtration Market size, by product, 2014-2025 (USD Million)


In addition, a large number of companies are investing heavily in manufacturing facilities worldwide. For instance, in October 2016, AbbVie Inc. invested around USD 320 million to construct a new facility in Singapore for small-molecule and biologic APIs production. Thus, the growth in the biopharmaceutical companies is projected to boost the demand for advanced products.

The technological progression by pharmaceutical filtration manufacturers has also resulted in the increasing adoption of these systems in the industry. The majority of the market players are constantly engaged in R&D to improve existing product portfolios and introduce novel technologies to aid in the sterilization of the media and the constituents. For instance, AstraZeneca, a leading healthcare company invested around USD 5,890 million in R&D in 2016.


Pharmaceutical Filtration Market Segmentation 

Based on the Product Insights, the market is segmented into membrane filters, prefilters & depth media, single-use systems, cartridges & capsules, filter holders, filtration accessories and others

  • In the product segment, membrane filters held the largest market share in 2016, owing to versatile usage in a wide range of applications such as ultrafiltration, nanofiltration, microfiltration, and cross-flow filtration. Since these membrane filters are used in a large number of applications they are also expected to substantially continue to gain market share during the forecast period.
  • The membrane filters segment is projected to witness growth at the fastest CAGR during the study period because of the rapid development of drugs and biologics companies. These companies are undergoing collaborations and partnerships to gain maximum share in the market.
  • The single-use systems segment is expected to grow at a significant CAGR during the forecast period. These systems provide several advantages including reduced risk of contamination, minimizes operation time, and provides ease of convenience. Thus, the demand for single-use systems is expected to rise in the near future. They are also compact in nature and take up less amount of space in factory settings. For instance, Allegro MVP Single-Use System developed by Pall Corporation can be used across various applications like sterile filtration, bioburden testing, depth filtration, virus inactivation, media, and buffer preparation.


Based on the Technique Insights, the market is segmented into microfiltration, ultrafiltration, crossflow filtration, nanofiltration and others

  • The microfiltration technique was the highest revenue-generating segment in the year 2016. Product advancement is one of the key driving factors for the segment. This technique is extensively used by manufacturers for the separation of large particles including proteins and yeast from a liquid feed stream.
  • The ultrafiltration segment is estimated to grow at lucrative growth due to varied applications of this technique in protein purification, vaccines, and antibody processes. The manufacturers are highly focused on delivering the exact needs of filtration processes in the healthcare industry.
  • The nanofiltration technique segment is projected to showcase a significant growth rate during the forecast period owing to innovations in nanofiber technology. The nanofibers are the innovative and next generation of nonwoven filter media, which deliver several unique properties such as good interconnectivity of pores along with the high potential to incorporate on a nanoscale.
  • Crossflow filtration is another technique that is gaining significant share owing to its increasing usage and added advantages such as filter cake flush away ability, long lifespan, and its deployment for the continuous separation process.


Based on the Application Insights, the market is segmented into final product processing, raw material filtration, cell separation, water purification and air purification

  • Final product processing held the largest share in the year 2016 owing to its large application in active pharmaceutical ingredient processing, protein purification, vaccine processing, antibody processing, and viral clearance. The final product processing segment is also projected to grow at the highest CAGR during the forecast period.
  • Cell separation is vital in various applications such as in the production of a monoclonal antibody, vaccine, and therapeutic protein to name a few. Microfiltration and depth filtration is used frequently for cell separation applications. The U.S., Germany, U.K., Japan, India, and China are projected to account for the large application of these products. The presence of leading healthcare companies, availability of advanced products along with a well-developed healthcare infrastructure in these regions contributes to market growth.
  • The air filtration market is anticipated to witness a significant growth rate during the study period. It is a vital process in all pharmaceutical and biopharmaceutical companies. The FDA has issued regulations and standards with respect to the manufacturing of drugs and biologics.


Based on the Scale Of Operation Insights, the market is segmented into manufacturing scale, pilot-scale and research & development scale

  • The manufacturing scale of operations held the largest market share owing to the increase in the production of biopharmaceuticals, generic drugs, and vaccines which are being used for the treatment of various diseases.
  • The manufacturing scale of operations is expected to continue to flourish during the forecast period as well on the account of increased demand for novel biologics and therapeutic proteins for the treatment of chronic diseases. The rising prevalence of chronic diseases like cancer, arthritis, and diabetes is expected to boost the segment’s growth.
  • The research and development scale segment is estimated to witness significant CAGR over the forecast period due to the rising investment in R&D for new technology and product development. For instance, the Pharmaceutical Research and Manufacturers of America (PhRMA) member companies have invested around USD 58.8 billion in 2015 for R&D.


Based on the Regional Insights, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

  • The North American region contributed the largest share by virtue of large dominant pharmaceutical and biopharmaceutical companies including Hoffmann-La Roche Ltd, Pfizer Inc., Merck KGaA, and Amgen Inc. in this region. Well-developed healthcare infrastructure and accessibility to advanced products in this region have fueled the growth of the regional market.
  • The European region is another dominant region in the market as a result of advanced healthcare infrastructure and the availability of technologically advanced products in the region. Increasing demand for biopharmaceuticals is also expected to drive growth in this region. European-based leading market players like Merck KGaA and Sartorius Stedim Biotech S.A. have a wide distribution network in the region. This enables the European region to capture a considerable share owing to the development of new systems and devices.
  • The Asia Pacific pharmaceutical filtration market is expected to witness the highest CAGR during the forecast period owing to untapped market potential in the region. The proliferation of pharmaceutical and biopharmaceutical companies in this region has resulted in immense growth.


Market Share Insights:

  • September 2016: Sartorius Stedim Biotech launched a novel ultrafilter Sartocon Slice 50, a new crossflow filter system, which is designed for various applications in the biotech industry including small-volume process development and membrane screening.
  • June 2016: Novartis and Xencor Inc. entered into a strategic collaboration where Novartis received rights to develop T-cell-engaging bispecific antibodies intended for acute myeloid leukemia and B-cell malignancies treatment.
  • August 2015: Danaher Corporation completed the acquisition of Pall Corporation and entered the filtration, separation, and purification solutions sector.
  • January 2013: Merck Millipore launched a new Mobius FlexReady Solution, a fully-automated system that is ready to set up, which makes it ideal for CMOs and pilot plants that have rapidly changing demands.


Key Companies Profile:

The dominant players provide an extensive product range and are constantly engaged in the expansion of their existing portfolios. The majority of these players have an intensified distribution network across a wide geographical region. The strong distribution channels, large product portfolio, and new product launches have led to intense competition among vendors. This has resulted in high pressure on pricing strategies that are expected to affect the profit margin of the vendors. 

Some prominent players in the global pharmaceutical filtration market include:

  • Eaton Corporation Plc
  • Merck KGaA
  • Amazon Filters Ltd.
  • GE Healthcare
  • Parker Hannifin Corporation
  • 3M
  • Sartorius Stedim Biotech S.A.
  • Graver Technologies, LLC
  • Danaher Corporation, Inc.


Order a free sample PDF of the Pharmaceutical Filtration Market Intelligence Study, published by Grand View Research.


About Grand View Research

Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.


Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States